AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Bavarian Nordic

AGM Information Apr 29, 2010

3354_iss_2010-04-29_edad2806-876d-4193-a690-e2b3f29b743b.html

AGM Information

Open in Viewer

Opens in native device viewer

Bavarian Nordic A/S - Notice convening extraordinary general meeting

Bavarian Nordic A/S - Notice convening extraordinary general meeting

Pursuant to Articles 10 and 16 of the Articles of Association, the shareholders
of Bavarian Nordic A/S are hereby convened to the extraordinary general meeting
to be held:

                  Tuesday, 25 May 2010 at 16.00 hours

at the Company's office, Hejreskovvej 10A, 3490 Kvistgård, Denmark, with the
following agenda:

1)  Any proposal from the Board of Directors or shareholders.

The Board of Directors has proposed the following resolutions:

a.   Amendments of the Articles of Association in consequence of the new Danish
Companies Act.

b.   Introduction of a new Article 5b authorizing the Board of Directors to
issue warrants, which entitles the holders to subscribe for shares of an
aggregated nominal value of up to DKK 4,000,000, hereof up to nominal DKK
300,000 to the Board of Directors.
b.
c.   Cancellation of Article 5e of the Articles of Association.

d.   Cancellation of the quorum requirement in Article 16 of the Articles of
Association.

2)  The Board of Directors requests the general meeting to authorise the company
during the period until the next Annual General Meeting to purchase its own
shares of up to a total nominal value of 10% of the company's share capital. The
payment must not differ by more than 10% from the bid price quoted on NASDAQ OMX
Copenhagen A/S at the time of the purchase.

3)  Any other business.

                            \* \* \* \* \* \* \* \*

Elaboration on the proposals:

Ad the agenda 1a) Amendments to the Articles of Association in consequence of
the new Danish Companies Act.

In consequence of the new Danish Companies Act the Board of Directors proposes
that the following amendments are made to the Articles of Association:

1.    Article 2 regarding the registered office of the Company is cancelled.

2.    The references in Article 5a to the Danish Public Companies Act sections
33, 79 and 80 are amended to the Danish Companies Act sections 160, 107 and 108.

3.    In Articles 5f and 17a "section 69b of the Danish Public Companies Act" is
amended to "section 139 of the Danish Companies Act".

4.    In Article 10, second paragraph, "the Greater Copenhagen area" is amended
to "the Capital Region of Denmark (in Danish Region Hovedstaden)".

5.    In Article 10, fourth paragraph, "by publication in one leading newspaper
and" is deleted and "The Board of Directors may resolve that notice to convene
the general meeting shall be published in a leading newspaper." is inserted
before "Furthermore".

6.    Article 10, sixth paragraph, is cancelled.

7.    In Article 11 "Each share amount of DKK 10 shall give one vote at General
Meetings." is inserted as the first sentence.

8.    Article 11, third paragraph, is amended to read as follows "The attorney
most provide a dated instrument of proxy issued to a person who need not be a
shareholder in the Company. Unless containing a provision to the contrary,
instruments of proxy shall be deemed to be in force until revoked in writing by
notification to the Company. However, instruments of proxy issued to the
Company's Board of Directors may not be issued for a period of more than 12
months and may only be issued in respect of a specific general meeting for which
the agenda is known in advance."

9.    In Article 14, last paragraph, the following is deleted "and a copy
thereof shall be sent to all shareholders who have so requested in writing".

10.  Article 15 is cancelled.

11.  In Article 16 "the Danish Public Companies Act" is amended to " the Danish
Companies Act".

Ad the agenda 1 b) Introduction of a new Article 5b authorizing the Board of
Directors to issue warrants.

The Board of Directors proposes that a new Article 5b with the following content
is introduced in the Articles of Association:

"During the period ending 31 December 2011, the Company may issue warrants, in
one or more portions by resolution of the Board of Directors. The warrants may
be issued to the management and employees of the Company or its subsidiaries,
including to consultants and the Company's Board of Directors, for the
subscription of shares of a nominal value of up to DKK 4,000,000 by cash
contribution at a subscription price and on such other terms as the Board of
Directors may determine. Notwithstanding the foregoing, the issuances of
warrants to members of the Board of Directors may not exceed a nominal value of
DKK 300,000. Any issuance of warrants to the Board of Directors or management
shall be made in accordance with the Company's policy for incentive remuneration
of the Board of Directors and the Management, prepared in accordance with
section 139 of the Danish Companies Act and approved by the general meeting, cf.
Article 17a of the Articles of Association.

Holders of warrants shall have pre-emption right to subscribe for the shares,
issued based on the warrants, meaning that the pre-emption rights to subscribe
to warrants and new shares for existing shareholders' are deviated from.

As a consequence of the exercise of awarded warrants, the Board of Directors is
authorised during the period until 1 April 2015 to increase the share capital by
a nominal value of up to DKK4,000,000 in one or more portions by resolution of
the Board of Directors by cash contribution at a subscription price and on such
other terms as the Board of Directors may determine without pre-emption right
for the existing shareholders.

The new shares issued based on warrants shall have the same rights as existing
shares according to the Articles of Association. The new shares shall be
negotiable instruments and shall be issued to the bearer, but they may be
registered in the bearer's name in the Company's register of shareholders. No
restrictions shall apply to the transferability of the new shares and no
shareholder shall be obliged to have his shares to be redeemed - in whole or in
part. The new shares shall carry the right to dividend from the time of
subscription."

Ad the agenda 1 c) Cancellation of Article 5e of the Articles of Association.

Article 5c of the Articles of Association provides the terms and conditions for
the exercise of 10,000 warrants issued by the Board of Directors pursuant to
authorisation. The employees to whom the warrants were issued have all
terminated their employment with the Company and their warrants have
consequently been annulled. On these grounds the Board of Directors proposes
that Article 5e is cancelled.

Ad the agenda 1 d) Cancellation of the quorum requirement in the Article 16 of
the Articles of Association.

The Board of Directors proposes that the following part of Article 16, last
paragraph, is cancelled

"and to not less than 50% of the share capital being represented at the General
Meeting in question. In case less than half of the share capital is represented
at the general meeting, but the resolution is passed by at least 2/3 of the
votes cast as well as of the votes represented at the general meeting, the
resolution may at a new general meeting called  within 14 days after the date of
the preceding general meeting be passed by 2/3 of the votes cast as well as of
the votes represented."

                            \* \* \* \* \* \* \* \*

The proposed resolutions under item 1 were adopted at the company's Annual
General Meeting on 27 April 2010 by no less than two-thirds of all votes cast
and of the voting share capital represented at the Annual General Meeting.
However, since less than one half of the share capital was represented at the
meeting the resolution could not be finally adopted. Pursuant to Article 16 of
the company's Articles of Association, resolutions passed by no less than
two-thirds of the votes cast and of the voting share capital represented at the
Annual General Meeting can be finally adopted, if the resolution are passed by
no less than two-third of both the votes cast and of the voting share capital
represented at an Extraordinary General Meeting. The proposed resolutions under
item 1, above, shall consequently be subject to the proposed resolutions being
adopted by no less than two-thirds of all votes cast and of the voting share
capital represented at the this Extraordinary General Meeting.

The Company's share capital amounts to DKK 119,120,520 divided into shares in
the denomination of DKK 1 and multiples thereof. Each share of a nominal value
of DKK 10 gives one vote.

Pursuant to Article 11 of the Articles of Association, shareholders who wish to
attend the General Meeting shall order admission cards no later than 21 May
2010. Admission cards may be ordered from Bavarian Nordic A/S at
www.bavarian-nordic.com , by tel: +45
3326 8383, by fax: +45 3326 8380, or for registered shareholders, who receive
the agenda/summon by mail, by submission of the enclosed order form. Capacity as
a shareholder shall be documented by his title having been entered in the
Company's Stock Register no later than one week prior to the general meeting or
by the Company having received his application for entry of the title in the
Stock Register before this date. It is emphasized that attendance of the General
Meeting requires the requisition of an admission card prior to the General
Meeting.

Shareholders may in writing submit questions to the Company regarding the
agenda, the documents to be presented at the General Meeting or the general
position of the Company. Questions may be submitted by mail or e-mail to
[email protected] . Questions will be
answered orally or in writing at the General Meeting.

Shareholders may vote by proxy. The attorney must provide a written and dated
power of attorney. The Company provides written and electronic power of attorney
forms. A written power of attorney form may be ordered from Bavarian Nordic A/S
at www.bavarian-nordic.com , by tel: +45
3326 8383, or by fax: +45 3326 8380 and is enclosed the agenda/summon that is
send by mail to registered shareholders, who have so requested. Moreover, the
Company may be advised about the appointment of an attorney at
www.bavarian-nordic.com .

The agenda for the General Meeting along with the full resolutions for adoption
will be on display for the shareholders at the Company's office, Hejreskovvej
10A, 3490 Kvistgård, Denmark, from the 3 May 2010. Moreover, the said documents
are sent by mail to registered shareholders, who have so requested. In addition
hereto, all documents that will be provided at the General Meeting, including
the agenda for the General Meeting along with the full resolutions, will be
published no later than 3 May 2010 on the Company's website,
www.bavarian-nordic.com .

Asger Aamund
Chairman of the Board

Contact
Anders Hedegaard, President & CEO. Phone +45 23 20 30 64

About Bavarian Nordic
Bavarian Nordic A/S is a leading industrial biotechnology company developing and
producing novel vaccines for the treatment and prevention of life-threatening
diseases with a large unmet medical need. The company's pipeline is focused in
the three areas; cancer, biodefence and infectious diseases, and includes seven
development programmes. Two programmes are under preparation for Phase III:
PROSTVAC(TM), a therapeutic vaccine for advanced prostate cancer is being
developed under a collaboration agreement with the National Cancer Institute,
and IMVAMUNE®, a third-generation smallpox vaccine is being developed under a
contract with the US government.

Bavarian Nordic is listed on NASDAQ OMX Copenhagen under the symbol BAVA.

For more information please visit www.bavarian-nordic.com

Forward-looking statements
This announcement includes "forward-looking statements" that involve risks,
uncertainties and other factors, many of which are outside of our control that
could cause actual results to differ materially from the results discussed in
the forward-looking statements. Forward-looking statements include statements
concerning our plans, objectives, goals, future events, performance and/or other
information that is not historical information. We undertake no obligation to
publicly update or revise forward-looking statements to reflect subsequent
events or circumstances after the date made, except as required by law.

[HUG#1409705]

Attachments:

  • 2010-24-uk


    This content was distributed through

    Hugin Group

    - connecting communication professionals with their target audience. Visit us here.

Talk to a Data Expert

Have a question? We'll get back to you promptly.